HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia

Journal of the Formosan Medical Association

Volumn 108, Issue 5, 2009, Pages 423-427

  Wu, Shang Ju ^a   Yao, Ming ^a   Tang, Jih Luh ^a   Ko, Bo Sheng ^a   Tien, Hwei Fang ^a   Chen, Yao Chang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; HLA DR; Parental donors

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; FLUDARABINE PHOSPHATE; HLA DR ANTIGEN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS; CANCER SURVIVAL; CELL MANIPULATION; CHEMOPROPHYLAXIS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DONOR LYMPHOCYTE INFUSION; ENGRAFTMENT; FATHER; FEASIBILITY STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LIVING DONOR; LUNG MYCOSIS; MALE; MORTALITY; MOTHER; NEUTROPENIA; PARENT; PILOT STUDY; VIRUS PNEUMONIA; VIRUS REACTIVATION; WHOLE BODY RADIATION;

EID: 67649586909     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60087-5     Document Type: Article

References (12)

1. Appelbaum FR. Allogeneic hematopoietic stem cell transplantation for acute leukemia. Semin Oncol 1997;24:114-123 (Pubitemid 27104909)
2. Thomas ED. Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases. J Clin Oncol 1983;1:517-531
3. Henslee-Downey PJ. Mismatched bone marrow transplantation. Curr Opin Oncol 1995;7:115-121
4. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985;313:765-771 (Pubitemid 15232310)
5. Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989;320:197-204. (Pubitemid 19034144)
6. nd edition. Academic Press, 2000.
7. Middleton D, Martin J, Douglas J, et al. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation 1994;58:845-848 (Pubitemid 24329191)
8. Lagaaij EL, Hennemann IP, Ruigrok M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989;321:701-705 (Pubitemid 19239700)
9. Waanders MM, Roelen DL, Brand A, et al. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Transfus Med Rev 2005;19:281-287 (Pubitemid 41415655)
10. Osarogiagbon RU, Defor TE, Weisdorf MA, et al. CMV antigenemia following bone marrow transplantation: risk factors and outcomes. Biol Blood Marrow Transplant 2000;6:280-288
11. Kanda Y, Mineishi S, Saito T, et al. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan. Bone Marrow Transplant 2001;27:437-444 (Pubitemid 32201353)
12. Doxiadis II, de Fijter JW, Mallat MJ, et al. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation 2007;83:1207-1213 (Pubitemid 46743682)